This pathway primarily activates the IRF3/NF-κB signaling cascade upon recognition of cytosolic DNA, leading to the production of IFN-β, which subsequently promotes immune cell activation and tumor antigen presentation (Dvorkin et al., 2024). The gene discussed is IRF3; the disease is neoplasm.